Skip to content
HowShorted

PMV Pharmaceuticals, Inc. short interest in 2026

In 2026, PMV Pharmaceuticals, Inc.'s disclosed short interest ran from 3.38% of shares outstanding on 15 Jan 2026 to 5.46% on 15 Sep 2026, a change of +2.08 percentage points. The year's high was 6.10% on 29 May 2026 and its low 2.32% on 27 Feb 2026, averaging 4.27% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.25 days on 15 Jun 2026. Full history: PMV Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PMV Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
3.38% (15 Jan 2026)
End of year
5.46% (15 Sep 2026)
Change
+2.08 pp
High
6.10% (29 May 2026)
Low
2.32% (27 Feb 2026)
Average
4.27%
Highest days to cover
11.25 (15 Jun 2026)
SEC filings marked
6

Every report in 2026

PMV Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20263.38%8.36
30 Jan 20263.48%5.56
13 Feb 20262.83%5.66
27 Feb 20262.32%1.40
13 Mar 20262.78%1.0010-K filed, results (8-K)
31 Mar 20262.93%3.98
15 Apr 20264.34%4.96
30 Apr 20264.94%7.60
15 May 20265.78%6.3110-Q filed, results (8-K)
29 May 20266.10%10.48
15 Jun 20265.38%11.25
30 Jun 20265.46%8.30
15 Jul 20264.54%6.26
31 Jul 20264.46%10.67
14 Aug 20264.20%5.9210-Q filed, results (8-K)
31 Aug 20264.24%8.45
15 Sep 20265.46%2.34

See also: PMV Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.